JUNGIĆ, S. M. i drugi. Efficacy and safety of bevacizumab in combination with irinotecan and capecitabine in first-line treatment of metastatic colorectal cancer. Vojnosanitetski pregled, v. 74, n. 3, p. 249–255, 20 Juni2017.